ENVB

Enveric Biosciences, Inc. Common Stock

1.46

USD

-0.04

-2.67%

Nov 04, 13:13 UTC -5

Open

Enveric Biosciences, Inc. Common Stock (ENVB) Earnings

ENVB Earnings Reports

Positive Surprise Ratio

ENVB beat 11 of 16 last estimates.

69%

Next Report

Date of Next Report

Nov 12, 2026

Estimate for Q3 26 (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Enveric Biosciences, Inc. Common Stock earnings per share and revenue

On Aug 12, 2026, ENVB reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q3 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Royalty Pharma plc Class A Ordinary Shares

Report Date

Nov 04, 2026 For Q3 26

Estimate

$1.20

Actual

$1.21

Surprise

+0.39%

BioNTech SE - ADR

Report Date

Nov 03, 2026 For Q3 26

Estimate

$0.80

Actual

$1.81

Surprise

+126.53%

Viridian Therapeutics, Inc. Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

-$0.98

Actual

-$0.81

Surprise

+18.04%

Alamar Biosciences, Inc. Common Stock

Report Date

Nov 03, 2026 For Q3 26

Estimate

-$0.21

Actual

-$0.19

Surprise

+12.96%

Harmony Biosciences Holdings, Inc. Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

$1.15

Actual

$0.81

Surprise

-30.03%

uniQure N.V.

Report Date

Nov 04, 2026 For Q3 26

Estimate

-$0.94

Actual

-$0.88

Surprise

+6.39%

UroGen Pharma Ltd. Ordinary Shares

Report Date

Nov 04, 2026 For Q3 26

Estimate

$0.13

Actual

-$0.03

Surprise

-121.79%

Geron Corp

Report Date

Nov 04, 2026 For Q3 26

Estimate

$0.00

Actual

$0.00

Surprise

+100.00%

Nuvectis Pharma, Inc. Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

-$0.24

Actual

-$1.02

Surprise

-313.79%

Ocugen, Inc. Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

-$0.05

Actual

-$0.06

Surprise

-3.81%

FAQ

What were Enveric Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Enveric Biosciences, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Enveric Biosciences, Inc. Common Stock's Q2 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Enveric Biosciences, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 12, 2026.

What are the forecasts for Enveric Biosciences, Inc. Common Stock's next earnings report?

Based on -- analysts, Enveric Biosciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.